Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;39(5):e14816.
doi: 10.1111/dme.14816. Epub 2022 Feb 24.

Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service

Bilal Bashir  1 , Panchami Elisaus  1 , Viktoria Chatzimavridou Grigoriadou  1 , Andrea Urwin  1 , Alyson Chapman  1 , Sheetal Ohol  1 , Lynne Ann Findlow  1 , Jody Foster  1 , Rachel Harwood  2 , Catherine Fullwood  2   3 , Jonathan Schofield  1   4 , Martin K Rutter  1   4 , Lalantha Leelarathna  1   4 , Hood Thabit  1   4
Affiliations

Real world effectiveness of clinically approved hybrid closed loop systems in a UK Secondary Care Diabetes Service

Bilal Bashir et al. Diabet Med. 2022 May.
No abstract available

PubMed Disclaimer

References

REFERENCES

    1. Boughton CK, Hovorka R. Automated Insulin Delivery in Adults. Endocrinol Metab Clin North Am. 2020;49(1):167-178.
    1. Leelarathna L, Choudhary P, Wilmot EG, et al. Hybrid closed-loop therapy: Where are we in 2021? Diabetes Obes Metab. 2021;23(3):655-660.
    1. National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management. https://wwwniceorguk/guidance/ng17 [Internet] 2015
    1. Battelino T, Danne T, Bergenstal RM, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019;42(8):1593-1603.
    1. Tauschmann M, Thabit H, Bally L, et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: A multicentre, 12-week randomised trial. Lancet. 2018;392(10155):1321-1329.

Publication types

LinkOut - more resources